Effects of typical and atypical antipsychotics on the prepulse inhibition of the startle reflex in patients with schizophrenia

Journal of Clinical Psychopharmacology

Volumn 22, Issue 4, 2002, Pages 359-365

  Oranje, Bob ^a,c   Van Oel, Clarine J ^a   Gispen de Wied, Christine C ^a   Verbaten, Marinus N ^b   Kahn, René S ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Department of Psychopharmacology ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; SERTINDOLE;

ADULT; AMPLITUDE MODULATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HABITUATION; HUMAN; MALE; MOTOR ACTIVITY; PREPULSE INHIBITION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PURE TONE AUDIOMETRY; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; STARTLE REFLEX; STIMULUS RESPONSE; TREATMENT PLANNING;

ACOUSTIC STIMULATION; ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA; STARTLE REACTION;

EID: 0036326767     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200208000-00005     Document Type: Article

References (46)

1. Gating and habituation of the startle reflex in schizophrenic patients
2. Sensory gating and inhibitory function in late-life schizophrenia
3. Startle gating deficits occur across prepulse intensities in schizophrenic patients
4. Elementary neuronal dysfunctions in schizophrenia
5. Startle habituation and sensorimotor gating in schizophrenia and related animal models
6. Habituation of the blink reflex in normals and schizophrenic patients
7. Prestimulus effects on human startle reflex in normals and schizophrenics
8. Preliminary evidence of an association between sensorimotor gating and distractibility in psychosis
9. Symptom correlates of prepulse inhibition deficits in male schizophrenic patients
10. Dopaminergic stimulation disrupts sensorimotor gating in the rat
11. The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by the noncompetitive glutamate antagonist MK-801
12. Towards a cross-species pharmacology of sensorimotor gating: Effects of amantadine, bromocriptine, pergolide and ropinirole on prepulse inhibition of acoustic startle in rats
13. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response
14. Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia
15. Genetics, haloperidol-induced catalepsy and haloperidol-induced changes in acoustic startle and prepulse inhibition
16. Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs
17. Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: Effects of antipsychotics and other agents in rats
18. Selective dopamine D4 receptor antagonists reverse apomorphine-induced blockade of prepulse inhibition
19. The cognitive efficacy of atypical antipsychotics in schizophrenia
20. Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats
21. Effects of clozapine in cognitive function in schizophrenia
22. Neuropsychologic deficits in schizophrenia: Relation to social function and effect of antipsychotic drug treatment
23. A comparison of the effect of clozapine with typical neuroleptics on cognitive function in the neuroleptic-responsive schizophrenia
24. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia
25. Information-processing deficits and thought disorder in schizophrenia
26. Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients
27. Normalization of information processing deficits in schizophrenia with clozapine
28. Prepulse inhibition of the startle response in men with schizophrenia: Effects of age of onset of illness, symptoms, and medication
29. The comprehensive assessment of symptoms and history (CASH): An instrument for assessing psychopathology and diagnosis
30. A diagnostic interview: The schedule for affective disorders and schizophrenia
31. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia
32. P50 suppression and prepulse inhibition of the startle reflex in humans: A correlational study
33. The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic inpatients
34. A historical perspective of clozapine
35. The effects of clozapine on cognitive functioning in schizophrenia
36. Serotonergic basis of antipsychotic drug effects in schizophrenia
37. Antipsychotics from theory to practice: Integrating clinical and basic data
38. An overview of the mechanism of action of clozapine
39. Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man
40. Effects of single oral administrations of haloperidol and d-amphetamine on prepulse inhibition of the acoustic startle reflex in healthy male volunteers
41. Chronic treatment with haloperidol diminishes the phencyclidine-induced sensorimotor gating deficit in rats
42. "Early" and "late" effects of sustained haloperidol on apomorphine- and phencyclidine-induced sensorimotor gating deficits
43. Seroquel restores sensorimotor gating in phencyclidine-treated rats
44. Dopamine in schizophrenia: A review and reconceptualization
45. Dopamine in schizophrenia
46. 2-receptor occupancy in clozapine-treated patients